2023

  1. Inflammatory bowel disease can reduce ovarian reserve function in women: A systematic review and meta-analysis

  2. Mesalamine multimatrix in pediatric UC

  3. Vedolizumab in children with IBD

  4. Neuroimmune modulation through vagus nerve stimulation in CD

  5. Golimumab, Guselkumab or both in UC

  6. Tofacitinib vs oral prednisolone in moderately active UC

  7. Over-the-Counter Multivitamin and Mineral Supplement to Prevent Infections in IBD Patients

  8. Ferric carboxymaltose vs Ferrous fumarate in Anemic children with IBD

  9. Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study